自然：克隆扩增CD细胞是肌萎侧索硬化-4（渐冻症）的特征

admin

《自然》：克隆扩增的CD8T细胞是肌萎缩性侧索硬化-4（ALS4，渐冻症）的特征

作者：小柯机器人

发布时间：2022/6/26 12:47:18

本期文章：《自然》：Online/在线发表

美国西奈山伊坎医学院Ivan Marazzi，Yesai Fstkchyan，Laura Campisi和美国加州大学欧文分校Albert R. La Spada共同合作，近期取得重要工作进展，他们研究发现克隆扩增的CD8T细胞是肌萎缩性侧索硬化-4（ALS4）的特征。相关论文2022年6月22日在线发表于《自然》杂志上。

研究人员利用携带ALS4致病性L389S突变的Setx基因敲入小鼠，描述了一种免疫学特征，该特征由敲入小鼠的中枢神经系统和血液中克隆扩大的终末分化的效应记忆（TEMRA）CD8 T细胞组成。基因敲入小鼠中抗原特异性CD8 T细胞的频率增加反映了运动神经元疾病的进展，并与抗胶质瘤免疫力相关。

此外，骨髓移植实验表明免疫系统在ALS4神经变性中起关键作用。在ALS4患者中，克隆扩增的TEMRA CD8 T细胞在外周血中循环。他们的结果提供了ALS4中抗原特异性CD8 T 细胞反应的证据，可用于揭示疾病机制并作为疾病状态的潜在生物标志物。

据介绍，肌萎缩性侧索硬化症(ALS)是一种异质性神经退行性疾病，影响运动神经元和随意肌控制神经元。ALS的异质性包括表现的年龄、进展的速度和症状出现的解剖学部位。特定基因中的致病突变已被确定并定义了ALS1的不同亚型。虽然一些与ALS相关的基因已被证明会影响免疫功能，但特异性免疫特征是否导致了ALS的异质性尚不清楚。肌萎缩性侧索硬化症-4(ALS4)的特点是发病年轻，进展缓慢。ALS4患者在30多岁时表现出运动障碍，大多数人在50多岁时就需要设备来辅助行走。ALS4是由senataxin基因（SETX）突变引起的。

附：英文原文

Title: Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4

Author: Campisi, Laura, Chizari, Shahab, Ho, Jessica S. Y., Gromova, Anastasia, Arnold, Frederic, Mosca, Lorena, Mei, Xueyan, Fstkchyan, Yesai, Torre, Denis, Beharry, Cindy, Garcia-Forn, Marta, Jimnez-Alczar, Miguel, Korobeynikov, Vladislav A., Prazich, Jack, Fayad, Zahi A., Seldin, Marcus M., De Rubeis, Silvia, Bennett, Craig L., Ostrow, Lyle W., Lunetta, Christian, Squatrito, Massimo, Byun, Minji, Shneider, Neil A., Jiang, Ning, La Spada, Albert R., Marazzi, Ivan

Issue&Volume: 2022-06-22

Abstract: Amyotrophic lateral sclerosis (ALS) is a heterogenous neurodegenerative disorder that affects motor neurons and voluntary muscle control1. ALS heterogeneity includes the age of manifestation, the rate of progression and the anatomical sites of symptom onset. Disease-causing mutations in specific genes have been identified and define different subtypes of ALS1. Although several ALS-associated genes have been shown to affect immune functions2, whether specific immune features account for ALS heterogeneity is poorly understood. Amyotrophic lateral sclerosis-4 (ALS4) is characterized by juvenile onset and slow progression3. Patients with ALS4 show motor difficulties by the time that they are in their thirties, and most of them require devices to assist with walking by their fifties. ALS4 is caused by mutations in the senataxin gene (SETX). Here, using Setx knock-in mice that carry the ALS4-causative L389S mutation, we describe an immunological signature that consists of clonally expanded, terminally differentiated effector memory (TEMRA) CD8T cells in the central nervous system and the blood of knock-in mice. Increased frequencies of antigen-specific CD8T cells in knock-in mice mirror the progression of motor neuron disease and correlate with anti-glioma immunity. Furthermore, bone marrow transplantation experiments indicate that the immune system has a key role in ALS4 neurodegeneration. In patients with ALS4, clonally expanded TEMRA CD8T cells circulate in the peripheral blood. Our results provide evidence of an antigen-specific CD8T cell response in ALS4, which could be used to unravel disease mechanisms and as a potential biomarker of disease state.

DOI: 10.1038/s41586-022-04844-5

Source: https://www.nature.com/articles/s41586-022-04844-5

https://www.nature.com/articles/s41586-022-04844-5

https://www.nature.com/articles/ ... =news.sciencenet.cn

https://news.sciencenet.cn/htmlp ... 12471869673714.shtm



自然：TDP-43 和 RNA 在再生肌肉中形成淀粉样蛋白样肌颗粒

Nature：TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle

https://www.nature.com/articles/s41586-018-0665-2



中国科学报 ： 新尿检法可追踪“渐冻人”病情发展

https://news.sciencenet.cn/sbhtmlnews/2017/2/320903.shtm
尿 p75 ECD
ALS 的预后、疾病进展和药效生物标志物
https://n.neurology.org/content/88/12/1137
Nature：中科院发现神经营养因子与受体的相互作用
https://www.nature.com/articles/nature07089

神经营养蛋白受体 p75
https://www.baidu.com/s?wd=%E7%A ... qP8DhsbrRS3niDNjQyU
https://www.google.com/search?q= ... chrome&ie=UTF-8



Nat:核转运问题或和肌萎缩侧索硬化症发病相关 RN蛋白
https://www.nature.com/articles/nature14973
https://news.bioon.com/article/6673819.html
http://www.kaseisyoji.com/forum. ... 2%E7%A1%AC%E5%8C%96



美国医院最新研究成果：比癌症还可怕的渐冻人症ALS治疗方法出炉！
http://cedars-sinai.com.cn/cedar ... cancer-is-released/

让罕见被看见——渐冻症相关药物及研发进展
http://www.phirda.com/artilce_28065.html?cId=1

【新发现】渐冻症“元凶”可能是它！
https://www.360zhyx.com/home-research-index-rid-73333.shtml

世界渐冻人日｜“肉跳”是渐冻症的征兆吗？
https://new.qq.com/rain/a/20230621A0ANWB00



华成旅行社  欢迎来电咨询：

电话：03-3833-9823  / 03-5688-1863
FAX ：03-3833-9873  / 03-3834-5891

SOFTBANK电话：080-3416-2275   担当：小郭  微信号：08034162275
SOFTBANK电话：090-2172-4325   担当：小于  微信号：TYOSCL4325
SOFTBANK电话：080-3398-4387   担当：小李  微信号：huacheng4387
SOFTBANK电话：080-3523-4388   担当：小何  微信号：huacheng602
SOFTBANK电话：080-3084-4389   担当：小马  微信号：huacheng858

http://www.kaseisyoji.com/forum.php?mod=forumdisplay&fid=10

admin

神经退化症之老痴、帕金、渐冻症、等、我小团队几年前都已解决、可打百分制的75分到85分。患者可惜可怜。

admin

渐冻症患者治疗
渐冻症患者佳音
根据微生物学、病理学、神经科学、药理学、内科学等专著和论文，肌萎缩性侧索硬化症(ALS，渐冻症)的第一位的治疗要项是抑制过度兴奋，可用伽马氨基丁酸类镇静助眠药物（便宜）、或抗谷氨酸药利鲁唑（较贵），第二位的治疗要项是抑制神经炎症反应，可用消炎解痛药、或激素类药，第三位的治疗要项是睡眠疗法，第四为其他、对症治疗等，均可口服药等简便方法治疗，可即时停止病情发展，并病情回复、回好约10-20%，救回大多数渐冻症患者宝贵生命。（2023.9.2晚10点写于东京）
(Translated by Baidu: )
According to monographs and papers in microbiology, pathology, neuroscience, pharmacology, internal medicine, and other fields, the first treatment requirement for amyotrophic lateral sclerosis (ALS) is to suppress overexcitation, which can be treated with gamma aminobutyric acid sedative and hypnotic drugs (cheap) or anti glutamic acid drug riluzole (more expensive). The second treatment requirement is to suppress neuroinflammatory reactions, which can be treated with anti-inflammatory and pain relieving drugs or hormone drugs, The third most important treatment option is sleep therapy, while the fourth is other, symptomatic treatment, which can be treated with simple methods such as oral medication. It can immediately stop the progression of the condition, and the condition can recover and improve by about 10-20%, saving the precious lives of most patients with Alzheimer's disease. (Written in Tokyo at 10pm on March 2, 2023)
（百度翻訳： ）
微生物学、病理学、神経科学、薬理学、内科学などの専門書と論文によると、筋萎縮性側索硬化症（ALS、漸凍症）の第1位の治療要項は過度の興奮を抑制することであり、ガンマアミノ酪酸系鎮静助眠薬（安価）、または抗グルタミン酸薬リノゾール（高価）、第2位の治療要項は神経炎症反応を抑制し、消炎解痛薬、ホルモン系薬、3位の治療要項は睡眠療法で、4位はその他、対症治療などで、いずれも薬を飲むなどの簡便な方法で治療し、直ちに病状の発展を停止することができ、そして病状の回復、回復は約10-20%で、多くの漸凍症患者の貴重な生命を救うことができる。（2023.9.2午後10時東京）

基因突变、遗传因素、免疫、病毒感染等在渐冻症的病因和发病机理中也有着重要作用。